At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 13 enrolled
Drug / intervention
Octreotide +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Octreotide on the Colonic Motility in Pediatric Patients
In Brief
A Phase 4 clinical trial evaluating Octreotide and Bisacodyl for Colonic Motility Index and Constipation. Completed, enrolled 13 participants across 1 site.
Detailed Summary
The research study is designed to test how a medication called octreotide affects the motility (contraction or squeezing) of the colon (large intestine). Investigators are investigating whether octreotide can increase contraction and movement in the colon.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColonic Motility Index, Constipation
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartAug 2013
First PostedAug 2013
Primary CompletionJun 2014
TodayJul 2026
First PostedAug 7, 2013
Enrollment StartAug 1, 2013
Primary CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 12.9 years ago
Interventions
Octreotidedrug
Average MI for all patients was calculated over 15-minutes, 30-minutes and 45- minutes before and after administration of octreotide
Bisacodyldrug